Business
This company has entered a trading halt, is it about to announce FDA approval?
Image source: Getty Images
Orthocell Ltd (ASX: OCC) is an Australian medical technology company focused on developing and commercialising innovative regenerative medicine treatments.
Over the last 12 months its share price has skyrocketed, up more than 260% in that span.
For context, S&P/ASX…
Continue Reading
-
Noosa News23 hours agoQueensland road rules state drivers must give way to pedestrians, cyclists and e-scooter riders entering or on slip lanes
-
General22 hours agoBody found in reserve in Sydney’s west potentially a middle-aged woman, police say
-
Noosa News20 hours agoJust as Cannes Did, Sydney Film Festival Has Awarded Its Major 2025 Prize to Jafar Panahi’s ‘It Was Just an Accident’
-
General17 hours agoChris Bowen must be sobbing over Albanese’s AI deal